Game-changer drug is the first to tackle overeating in Prader-Willi syndrome A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.

https://www.drugdiscoverynews.com/game-changer-drug-is-the-first-to-tackle-overeating-in-prader-willi-syndrome-16355?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-_AhFv4CFaqtv-XOdvk7IdIvVBjj_WNH8JAeNS8QYHdu5xxTKHsProh-3imzYyl15IPwEE3P8YQmMjRLtRYVCsGUHcX7A&_hsmi=360625489&utm_content=360625489&utm_source=hs_email